CBP-501

Overview

CBP-501, a cell-permeable calmodulin -binding peptide and a G2-abrogating drug candidate, inhibits the activity of multiple Ser 216 -specific kinases, such as MAPKAP-K2 , C-Tak1 , CHK1 and CHK2 , with IC 50 values of 0.9 μM, 1.4 μM 3.4 μM and 6.5 μM, respectively. CBP-501 is used for various types of cancer .

Application

Products | Products > Peptides | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > Calmodulin | Products > Signaling Pathways > Checkpoint Kinase (Chk) | Products > Signaling Pathways > MAPKAPK2 (MK2) | Products > Signaling Pathways > MAP3K

Product Information

• Catalog No.: HY-16129
• CAS No.: 565434-85-7
• Molecular Formula: C86H122F5N29O17
• Molecular Weight: 1929.06
• Purity: 99.98%
• Storage: Sealed storage, away from moisture. Powder -80°C, 2 years , -20°C, 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Source

Original product source